Good afternoon, ladies and gentlemen, my name is Julie and I will be your conference operator today. At this time I would like to welcome everyone to the Celestica Third Quarter Earnings Call. All lines have been placed on mute to prevent any background noise. After the speaker’s remarks there will be a question-and-answer session. [Operator Instructions] I would now like to turn the call over to Paul Carpino, Vice President of Investor Relations. Paul you may begin.

Good afternoon and thank you for joining us on Celestica’s Third Quarter 2018 Earnings Conference Call. On the call today are Rob Mionis, President and Chief Executive Officer; and Mandeep Chawla, Chief Financial Officer. As a reminder, during this call, we will make forward-looking statements within the meanings of the U.S. Private Securities Litigation Reform Act of 1995 and applicable Canadian Securities Laws, including those related to; our future growth; trends in the EMS industry, generally and in relation to our business; our anticipated financial and/or operational results, and our anticipated non-IFRS adjusted annual effective tax rate; our targets, priorities, guidance, plans and initiatives, the sale of our Toronto headquarters; our intention to launch a NCIB; the timing, amounts and benefits anticipated from our cost efficiency initiative; the anticipated impact of our comprehensive review of our CCS business; the expected timing of our anticipated acquisition of Impakt and anticipated restructuring actions in capital expenditures. Such forward-looking statements are based on management’s current expectations, forecasts and assumptions, which are subject to risks, uncertainties and other factors that could cause actual outcomes and results to differ materially from conclusions, forecasts or projections expressed in such statements. For identifications and discussion of such factors and the material assumptions on which such forward-looking statements are based as well as further information concerning financial guidance, please refer to the Company’s various public filings. These include our most recent MD&A and annual report on Form 20-F, filed with and in reports on Form 6-K furnished to the U.S. Securities and Exchange Commission and, as applicable, the Canadian Securities Administrators including the Risk Factors section thereof. Please also refer to our cautionary statements regarding forward-looking information in such filings and in today’s press release. Our public filings can be accessed at sec.gov and sedar.com. We assume no…

Thanks, Paul, and good afternoon. Celestica delivered strong revenue growth and continued consolidated margin expansion in Q3. Mandeep will provide more details on the quarter but let me highlight a few items. First, we were very encouraged by the improvements made in our CCS segment, which for the second straight quarter has delivered solid revenue growth and has moved towards the higher end of our target CCS margin range. As we have highlighted throughout transformational journey. We believe a strong and focused CCS segment is essential to delivering on our strategic initiatives and we continue to make progress in this regard. Second, we like how the diversification and strength within CCS helped offset some of the pressure we saw in our semiconductor capital equipment business. CCS revenue and segment margin has steadily recovered since the beginning of the year and we are encouraged by the results of our investments including in JDM, which is having another year of double-digit revenue growth. Third the integration of Atrenne is substantially complete and meeting our objectives. With Atrenne we were able to acquire and successfully integrate a business with a proven operational track record. And we are looking forward to the integration of Impakt later this year. And finally I am pleased with continued consolidated non-IFRS operating margin expansion this quarter. Now with our Q4 guidance, where we are targeting to report additional improvement. The continued progression in our margin initiatives is key to supporting our recently increased and accelerated non-IFRS target operating margin range of 3.75% to 4.5% over the next 12 to 18 months. As previously highlighted, there are three main components to these initiatives. First anticipated benefits from our $50 million to $75 million restructuring program, which is scheduled to run until mid-2019. Second the ongoing expansion of our EPS…

Thank you, Rob and good afternoon everyone. Celestica reported strong revenue of $1.71 billion, an increase of 12% year-over-year and exceeded the midpoint of our revenue guidance range. Our non-IFRS operating margin was 3.3%, up 20 basis points from the second quarter and in line with the midpoint of our revenue and non-IFRS adjusted EPS guidance ranges for the quarter. Adjusted earnings per share were $0.26 at the low end of our guidance range. We had a $0.03 per share negative tax impact arising from taxable foreign exchange, primarily from the weakening Chinese renminbi relative to the U.S. dollar, as well as an increased proportion of profits earned in higher tax rate jurisdictions. In ATS, we saw year-over-year revenue growth of 17% driven by new program revenue in aerospace and defense including contributions from our recent acquisition of Atrenne and demand strength in industrial. Some of this growth was offset by demand weakness in capital equipment reflecting the well documented cyclical moderation currently being experienced in the semiconductor capital equipment component of this business. For the third quarter of 2018, ATS segment income was $25.5 million and ATS margin was 4.6% down 50 basis points from Q2 and slightly below our target ATS segment margin range of 5% to 6%. This decline was primarily driven by lower utilization in our capital equipment business. Our CCS revenue was strong in the third quarter, led by better demand in both Communications and Enterprise end markets, including JDM. Overall CCS revenue was up 9% year-over-year and up 1% sequentially. CCS segment income was $30.9 million, translating to a margin of 2.7%, a solid 50 basis points increase from Q2 resulting from improved mix and operational performance. CCS segment margin in the third quarter was also up 100 basis points from the first quarter…

[Operator Instructions] Your first question comes from Robert Young with Canaccord Genuity. Robert, your line is open.

Hi, good evening. First question for me would be a clarification on the $500 million of CCS segment revenue you’re looking at reducing by. You didn’t give a range there. So is that a maximum figure? Can you give maybe some context around that number? And I was also interested in the clarifying you said that you expect single-digit percent reduction in total revenue. I assume that’s 2019. And does that include any contribution from the acquisition of Impakt?

Hey Rob, this is Rob. So starting with a portfolio review, at this stage we’ve done a exhaustive review of our $4.4 billion CCS portfolio and based on that, as we said in the earlier the $500 million of revenue is something we’re looking to take out over the next 12 to 18 months. Again, our focus is on really improving the overall economics of the business, while continuing to provide great support to our customers. From an overall company perspective, we’re anticipate that our revenues will be down in the single digits year-over-year next year. And that is while we expand margins, while we expand earnings and while we generate cash. However, as I mentioned on the call, this is somewhat variable because our base business might grow. Our contract is based on a broad market demand. But broadly speaking, we view this as a value creating activity. And I’ll turn it over to Mandeep for the second part.

Rob, I think the question was answered. So from a 2019 perspective, I would think about the revenue is being down in the single digits on a consolidated basis, including the Impakt and growth in ATS.

Okay. So it does include Impakt. And the second question you said that you’re bidding on and winning new business. And so I was wondering, you could talk about the dynamic between the rationalization of CCS, but at the same time winning new businesses is that, are you meaning any new opportunities or you are unable to win some new opportunities because of this? Is it changing the dynamic with some customers? If you can talk about the Impakt on the front line.

Yes. Overall, we’ve had a very strong bookings in both segments, specifically in CSS. We’re looking for work that plays to our strength specifically in JDM, we’re having a great year in JDM. Our growth should be north of 20%. We’re also continuing to win work in core EMS as well. That plays to our strength of higher complexity, higher liability. The portfolio reviews are really program specific and largely on the work that has kind of less calories, if you will.

Robert, the only thing I’d add to that as well is the $500 million is the net number, if you will, of revenue that will come out of the portfolio reviews now then underway for some time we’ve been making a lot of good progress, meaning our conversations with a number of customers. We have been successful in renegotiating commercial terms to our benefit. And along with that, collaborating with our customers and generating new wins. When we’ve identified the $500 million those are programs where we just agreed together that the investment that we’re making and the return that’s going to come just don’t really match up together.

Okay. And if I can ask one last one, just an update on the semiconductor equipment business. I noticed in call that the capital equipment business. Are you changing the name of it to include no Impakt and – you said that you expected a pause last quarter, are expecting that to change past the line?

Yes. So with Impakt coming online, we’ll review the entire portfolio of the capital equipment business. So it has an industrial sector, has a power sector, has a semiconductor capital equipment business, and it has a display business and that overall is our capital equipment business. With respect to semi cap, it has been a good business for us even through the cycle bookings has been especially strong this year. We do view Q4 as flattish relative to Q3 from a revenue perspective.

Okay. That’s it.

That’s Rob. Next question Julie.

Your next question comes from Thanos Moschopoulos with BMO. Thanos, your line is open.

Hi, Rob. As you go through the portfolio review process in CCS what do you think that would do for your targeted margin range there?

Hey Thanos, Mandeep here. Going back to some of the remarks that were made as we have laid out the expansion of the margins to 3.75% to 4.5% over the next 12, 18 months. It’s been driven by a series of initiatives. One of them absolutely is this CCS portfolio review. But it’s also being driven by the continuing growth in ATS as well as the expanding margins that we’re seeing from the productivity program that’s well underway right now. As mentioned, we spent $37 million towards the $50 million to $75 million program. And as you saw in the results this quarter from CCS, we’re starting to see the benefit to really hit the bottom line. So it’s a combination of those three initiatives together.

I guess the question was more around what would be targeted range they’ll be as we look at longer-term. I mean, we should be thinking about maybe 2% to 4%, would that be achievable? Or I guess, should we wait until you get through the process where we talk about targets?

We think the target range of 2% to 3% continues to be the right target for the CCS business. It was stronger this quarter. The productivity actions have been helping, but there was also a benefit of mix. As we continue to execute the portfolio review, it will allow us to stay within this range more predictably. And so we think that 2% to 3% range continue, when you look it from a company mix perspective, as we continue to grow the ATS portfolio as we ramp new programs and integrate the Atrenne and Impakt acquisitions, we would be working to scale into the higher end of that range, which is 5% to 6% as you know. And then through the mix of the portfolio, that’s how we believe we can get to the 3.75% plus.

Okay. And then can you update us on the tariff situation in terms of how your thinking is evolving maybe in terms of the potential impact on your business and whether – and to what extent is playing a role in your customer discussions?

Yes, it’s certainly a lot more active, Thanos, over the last couple of months. Customers who are actually buying hardware for their own use, they’ve been more active than classical OEMs. And they have been very anxious and quoting new programs and other regions outside of China. The classical OEMs have been more measured and their actions and working towards more balanced supply chain. So far customers have not opted to kind of move programs from where they are now. So the activity is largely on next generation programs moving forward. Based on our footprint and where our capacity is, we do think we might be in net benefactor of the disruption in the supply chain. That being said, we’re going to be very deliberate on the programs that we choose to go after relative to the portfolio review that we’re currently under billing.

Okay. Thanks Rob, with that point.

Great. Thanks Thanos. Next question, Julie.

Your next question comes from Daniel Chan with TD Securities. Daniel, your line is open.

Thanks for taking my question. I just wanted to expand on that question around the margin impact from the $500 million. On to the programs that you’re looking at within those $500 million, what is the financial – what are the finances look like around those programs, talking about like margins and ROIC, because in the past you’ve been able to get ROIC – high ROIC from low margin programs. Is that something that you’re looking at you?

Yes. Hi, Dan, it’s nice to talk to you. The primary focus for our review is a ROIC. It’s ROIC. And so with the current constrained inventory environment and with just growth in overall invested capital, what could have been a good ROIC program at the outset, could unwind sometimes quite quickly and when you have very thin margins. There’s variability there as well. So our focus is on ROIC sometimes it’s going to result in better pricing, sometimes that’s going to result in better commercial terms around investments that we’re making within the business. And so we’re looking at it from all angles and for the programs, where we’ve already been able to negotiate better terms, it’s addressed both of those areas.

And the margin profile on the $500 million, should we expect that to be kind of like in the low 2% range or below that.

So the margin profile often is a diluted to the overall CCS portfolio. If you were to look at the programs, they are predominantly on the fulfillment side. And so again, as you stated up front, the nature of those types of programs typically have the lower margins. Although often good ROIC, when they’re performing well.

Okay, great. Thank you.

Thanks Dan.

Thanks, Dan. Next question, Julie.

Your next question comes from Matt Sheerin with Stifel. Please go ahead.

Yes, thank you. Just couple of questions for me, relative to the $500 million revenue number in terms of the portfolio review does that include the news recently that one of your customers is moving business away, which I think was deliberate on your part. Is that part of that $500 million or is that incremental to that?

Matt, it’s Rob. That is part of it. I can’t comment on specific customer activity, but what I can do that action of the $500 million that we’ve just announced with regard to our portfolio review, that customer comment was part of that review. And it goes to say that sometimes we decided to – with our customers decide to exit certain programs and in other cases, we decide to grow different programs within that customer. So these are really program by program, location by location kind of decisions that we workout with our customers.

Got it. And as you do, you deselect, you obviously will open up capacity and you’ve got equipment in place. But I imagine that all that equipment is fungible, where you can move it for our other programs. So when there is opportunity to backfill with higher margin, then that should help in terms of your CapEx.

Absolutely, Matt. We continue to optimize the portfolio as programs come down to lights and other programs that we’re quoting on. We’re looking at it holistically; much of the CapEx that we do use is interchangeable between our sites and we also believe I’ll make a note again that the $500 million dollar review there, any restructuring charges that would go along with it would be contained in our existing program of $50 million to $75 million.

Got it, okay. And then just a follow-up on the tariff question, it sounds like you and other EMS companies are having a lot of conversations with customers about potentially moving capacity if indeed, particularly, if there’s a 25% tariff on communications equipment in the U.S. but are you actually – is there actually plans in place, where you’re actively quoting and looking at moving business now and how close are you in terms of customers and in terms of the cost is obviously, got to be a cost relative to moving equipment inventory build ahead of that and is that something that you think that you’ll be able to pass along to customers or would that be something that you’ll have to share with?

Yes. Most of the activity that has been really on next generation programs. So, it would be no lead time away from when these new products get introduced and ramped, very limited action right now, more point solutions on moving existing product around and if it would require additional CapEx or major investments that will – would all be taken into account in terms of our proposals with our customers and moving forward.

Okay. All right. Thanks a lot.

Thanks, Matt.

Next question, Julie.

Your next question comes from Gus Papageorgiou with Macquarie. Please go ahead.

Okay. Thanks. first as a clarification, Mandeep, did you say that there were three customers account for 10% of revenue each?

Two customers in the quarter.

Okay. So, just on the inventory, you mentioned in your press release that you had to take additional inventory provisions and the inventory days continued to remain stubbornly high, and when do you – so kind of around that, when do you think your inventory days will kind of normalize, and in terms of the additional inventory provisions, I think this is maybe the second quarter you mentioned that, I mean, how much – how much risk is there in terms of your balance sheet and what can we expect from those breakdowns?

Yes. So, Gus, the inventory did grow slightly quarter-to-quarter. It was up about $50 million or so. So, as you’ll notice that there’s guidance that we have provided, we are continuing to see strong revenue growth and we’re seeing growth in Q4 from Q3. And so we do support that. The constraint material environment, it continues to be a challenge. We are seeing some areas improve, but we’re seeing other areas that continue to be quite stubborn. MLCC continued to be an area with very long extended lead times. Our viewpoint right now is, is that the environment will improve closer to the back half of 2019, but it’s a dynamic situation as you know, and it does change quarter to quarter. I will make the point, which I’ve made in the past, which is ultimately; the inventory is the liability of our customers. And so while we had been building the inventory, it ultimately does go back to them. from a provision’s perspective, our provision rates continue to be in line with the normal aging of our inventory. Our write-off history is actually a quite lower than our provisions. We have, at times, taken more conservative approaches towards the way we do our provisioning. And so again, as that inventory unwinds, we would expect that there will be an opportunity there as well.

Okay, great. Thank you very much.

Thanks. Gus.

Thanks. Next question, Julie.

Your next question comes from Todd Coupland with CIBC. Please go ahead.

Yes, good evening everyone.

Good morning.

I just wanted to clarify on the EPS and the quarter. So the adjusted number of $0.26 that was at the higher tax rates. So, your comment of the $0.03 hit from FX and the higher tax rate was not included in that $0.26, is that right? So, sort of an adjusted-adjusted number would be higher. Is that what you meant when you said that?

That’s right. So we did hit the midpoint of our guidance, as you know, todd, with revenue relatively at the midpoint. So, the 3.3% was in line with our guidance, but we were at the low end of the EPS range, because of $0.03 of additional taxes. And so that was made up primarily of taxable effect, but also tax that landed in other jurisdictions. If we were to normalize for those, we would have expected our adjusted EPS to be at the midpoint of our target.

Great. And the mix issue of semi drag and better mix in CCS sort of offset each other, which I guess ultimately got to yet number as well.

No.

Okay. And my second question is, with respect to free cash flow goals in the past, I think you’ve had a running target of a $100 million to $200 million per year. How are you thinking about 2019 with all the moving parts that you’ve called out of inventory constraints and portfolio review, better margins, et cetera. Just give us your thoughts on what free cash flow might look at – look like next year? Thanks.

Sure, Todd. We’re pleased that we’re able to generate positive free cash flow this quarter after as you know, a number of quarters of a negative free cash flow mainly due to the increasing levels of inventory. The thing I’ll point out though is the revenue for this year is on track to be up almost $500 million on a year-over-year basis. And so while the constraint inventory environment has definitely contributed to it, we’ve been also growing along the way our inventory to support the revenue. With the guidance that we’ve – actually, I’ll correct that we’re not giving guidance, but with the goalpost that we provided for 2019, which is that the revenue would likely be down in the single digits. We would expect that that would not happen again. And so as you know, in our industry as revenue unwind inventory also unwind. And so all things being equal, we expect 2019 will be a year of positive free cash flow and when the inventory environment does start to unwind, we expect that there’ll be some additional benefits coming.

So with that happening are you saying you could see a free cash flow above what your normal goal is or it just gets you into year-over-year typical range?

No. So our inventory is up almost $250 million or close to $300 million year-over-year eventually that unwind, when we give our target of $100 million to $200 million on a normalized basis. And so eventually as that inventory unwinds, we would expect it to be an addition to the targets that we were.

Okay, great. Thanks very much.

Thanks, Todd.

Next question, Julie.

Your next question comes from Paul Treiber with RBC Capital Markets. Please go ahead.

All right. Thanks very much and good afternoon. First on a clarification question just for Q4, your outlook for Q4, does that include any expected contribution from Impakt?

Hey Paul, good to talk to you. So we are currently anticipating that Impakt will close in late fourth quarter. We have included, our guidance does include Impakt closing, but we expect that the contribution from a revenue and profit perspective from Impakt is going to be not material and so it is included in our fourth quarter guidance.

Great. Thanks for that. Just – the second question is a follow-up to some of the tariffs, the comments you made on the tariff situation, does that apply to the existing tariffs or does it also take into account that a possible increased to the next level of tariffs the $270 billion?

Yeah, it probably applies to the existing tariffs in anticipation of it being notched up a level here in the beginning of the year. I don’t see, but it could be wrong, I don’t see, customers moving existing product around that really more focused in on next generation products and having a more balanced supply chain maybe in the past some of our customers have over rotated what supply chains in China and I think in this new world that we’re in looking to have more of a balanced portfolio in terms of where their capacity is, and I think they’re quoting activity looks like it’s aligning to that for the next generation of products.

That’s helpful. Just lastly, on JDM, I mean obviously it’s been very healthy. Could you just elaborate on the trends that you’re seeing in the JDM business right now, just particularly in regards to end customers as well your traditional OEMs versus maybe non-traditional customers?

Yes. So we service both the traditional OEMs and non-traditional customers, and our broad JDM business is benefiting from increased deployment of data centers. Our go-to-market approach non-classical customers is largely through the JDM portfolio and with the growth in data centers, that’s one of the main drivers for it. Our portfolio within JDM is fairly balanced between communications and enterprise, and it’s been growing at a very nice quip. As I mentioned earlier, I think this year we’re on target to go north of 20% year-over-year and we have a strong pipeline of products and programs and customers, and our products are performing very well in the marketplace and it’s really an alternative to ODM. We don’t again view us as competing with the OEMs, so our customers really view it and the market views as an alternative to the ODMs and it’s been received very well in the marketplace.

Thanks. I’ll pass on.

Thanks Paul. Next question, Julie?

Your next question comes from Jim Suva with Citi. Please go ahead.

Hi, this is Josh here on behalf of Jim Suva, what is the revenue level needed for achieving your target operating margins that’s 3.75% to 4.5% over the next 12 to 18 months?

Yes. Hi, Mandeep here. So we believe that we were able to get to that level knowing that 2019 is going to be down likely in the single digit range and so, if you were to dissect that a little bit, we expect to see continuing growth in our ATS business. Our organic growth rate, our long-term target is 10% in addition to any acquisitions that we’re able to add onto that business. So the Impakt also contributing to the overall margin expansion opportunity in ATS, and then on CCS, you know, it is not going to be a revenue story, it is going to be continuing productivity and portfolio optimization and so – but on an overall basis, we would expect that we would see continuing margin expansion in 2019 with EPS growth as well, so what revenue would be.

Thank you.

Thanks Josh. Any questions? Additional questions, Julie? There are no further questions at this time. I will now turn it back over to you, Paul.

Thanks Julie. I’m excited that we’re able to sign Impakt earlier this month. It’s a great business that’s well positioned than a large growing, technically demanding market. I think we’re continuing to make very good progress on executing our strategy. We have great momentum across all our major priorities and we’re working towards a more diversified and profitable enterprise, Mandeep and I look forward to updating you on our progress in the next quarter. Thank you all and have a good evening.

This concludes today’s conference call. Thank you for your participation and you may now disconnect.